MAPT and amyloidosis: This is specifically proposed by the amyloid hypothesis and suggests that tau is a more proximal effector of toxicity than Aβ, which would be in keeping with the observation that tau pathology correlates better with cognitive status than amyloid pathology in AD patients [60].